Sector: Health Care
Director information for BRIDGEBIO PHARMA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Ali J. Satvat | Director | 48 | [] | [] | 2026 |
| Andrea J. Ellis | Director | 40 | [] | [] | 2026 |
| Andrew W. Lo, Ph.D. | Director | 65 | [] | [] | 2026 |
| Charles Homcy, M.D. | Director and Lead Director | 77 | [] | [] | 2026 |
| Douglas A. Dachille | Director | 61 | [] | [] | 2026 |
| Eric Aguiar, M.D. | Director | 64 | [] | [] | 2026 |
| Frank P. McCormick, Ph.D., F.R.S., D.Sc. | Director | 75 | [] | [] | 2026 |
| Fred Hassan | Director and Lead Independent Director | 80 | [] | [] | 2026 |
| Hannah A. Valantine, M.D. | Director | 74 | [] | [] | 2026 |
| James C. Momtazee | Director | 54 | [] | [] | 2026 |
| Jennifer E. Cook | Director | 60 | [] | [] | 2026 |
| Neil Kumar, Ph.D. | Chief Executive Officer and Director | 47 | [] | [] | 2026 |
| Randal W. Scott, Ph.D. | Director | 68 | [] | [] | 2026 |
| Ronald J. Daniels | Director | 66 | [] | [] | 2026 |
